Evidence map›Paper›PMID 19451188›Full record

ArticleCarcinogenesis2009

Sequestration of E12/E47 and suppression of p27KIP1 play a role in Id2-induced proliferation and tumorigenesis.

Valerie A Trabosh, Kyle A Divito, Baltazar D Aguda, Cynthia M Simbulan-Rosenthal, Dean S Rosenthal

Open access · bronzeAbstract read
In one paragraph

Article in Carcinogenesis, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. E47 Governs the MYC-CDKN1B/p27Cellular and molecular gastroenterology and hepatology · 2018
    Article
  5. Downregulation of Id2 increases chemosensitivity of glioma.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2015
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. The function of p27 KIP1 during tumor development.Experimental & molecular medicine · 2009
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Valerie A TraboshDepartment of Biochemistry and Molecular Biology, Georgetown University School of Medicine, 3900 Reservoir Road NW, Washington, DC 20007, USA.
Kyle A Divito
Baltazar D Aguda
Cynthia M Simbulan-Rosenthal
Dean S Rosenthal
Georgetown University · USThe Ohio State University · US

Funding

Id proteins in UV-mediated keratinocyte apoptosisR01CA100443 · NCI · GEORGETOWN UNIVERSITY · PI ROSENTHAL, DEAN · 2004 to 2008
$851k
NCI NIH HHS 1R01 CA 100443-01A1NCI NIH HHS R01 CA100443
6 · The paper itself

Abstract

Id2 is a member of the helix-loop-helix (HLH) family of transcription regulators known to antagonize basic HLH transcription factors and proteins of the retinoblastoma tumor suppressor family and is implicated in the regulation of proliferation, differentiation, apoptosis and carcinogenesis. To investigate its proposed role in tumorigenesis, Id2 or deletion mutants were re-expressed in Id2(-/-) dermal fibroblasts. Ectopic expression of Id2 or mutants containing the central HLH domain increased S-phase cells, cell proliferation in low and normal serum and induced tumorigenesis when grafted or subcutaneously injected into athymic mice. Similar to their downregulation in human tumors, the expression of cyclin-dependent kinase inhibitors p27(KIP1) and p15(INK4b) was decreased by Id2; the former by downregulation of its promoter by the Id2 HLH domain-mediated sequestration of E12/E47. Re-expression of p27(KIP1) in Id2-overexpressing cells reverted the hyperproliferative and tumorigenic phenotype, implicating Id2 as an oncogene working through p27(KIP1). These results tie together the previously observed misregulation of Id2 with a novel mechanism for tumorigenesis.

Indexed as

AnimalsCell ProliferationCells, CulturedCell Transformation, NeoplasticCyclin-Dependent Kinase Inhibitor p15Cyclin-Dependent Kinase Inhibitor p27FibroblastsHelix-Loop-Helix MotifsInhibitor of Differentiation Protein 2MiceMice, KnockoutNeoplasm TransplantationS PhaseTCF Transcription FactorsTranscription Factor 7-Like 1 ProteinCdkn1b protein, mouseCdkn2b protein, mouseCyclin-Dependent Kinase Inhibitor p15Cyclin-Dependent Kinase Inhibitor p27Idb2 protein, mouseInhibitor of Differentiation Protein 2TCF7L1 protein, humanTcf7l1 protein, mouseTCF Transcription FactorsTranscription Factor 7-Like 1 Protein

Identifiers

PMID19451188
PMCPMC2704286
OpenAlexW2121827818

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.